Search This Blog

Thursday, February 28, 2019

Eagle Pharmaceuticals reports Q4 non-GAAP EPS $1.20, consensus $1.16

Reports Q4 revenue $, consensus $54.17M.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)